phosphorylcholine and cardiovascular agents

phosphorylcholine has been researched along with cardiovascular agents in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, J; Arnold, N; Chan, KH; Cumberland, DC; Gunn, J; Holt, CM; Malik, N; Stratford, P; Vick, T1
Bonan, R; Fajadet, J; Fitzgerald, PJ; Kuck, KH; Kuntz, RE; Laarman, GJ; Münzel, T; Ormiston, J; Popma, JJ; Wijns, W1
Abizaid, A; Centemero, M; Chaves, A; Feres, F; Fitzgerald, PJ; Lansky, AJ; Mattos, L; Schwartz, LB; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF; Zaugg, MJ1
Abizaid, A; Costa, Jde R; Feres, F; Hattori, K; Larracas, C; Popma, JJ; Schwartz, LB; Solberg, B; Tanajura, LF1
Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG1
Nakagawara, J; Ogasawara, K; Shirao, S; Suzuki, M; Tominaga, T; Yoneda, H1

Trials

4 trial(s) available for phosphorylcholine and cardiovascular agents

ArticleYear
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.
    Minerva cardioangiologica, 2007, Volume: 55, Issue:1

    Topics: Aged; Australia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Double-Blind Method; Drug Delivery Systems; Equipment Design; Europe; Female; Humans; Israel; Male; Middle Aged; New Zealand; Pacific Islands; Phosphorylcholine; Prospective Studies; Sirolimus; Stents; Treatment Outcome

2007
Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    The American journal of cardiology, 2007, May-15, Volume: 99, Issue:10

    Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorylcholine; Prospective Studies; Prosthesis Design; Research Design; Sirolimus; Stents; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional

2007
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:8

    Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States

2009
A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study.
    World neurosurgery, 2014, Volume: 81, Issue:2

    Topics: Aged; Arachidonic Acid; Cardiovascular Agents; Combined Modality Therapy; Eicosapentaenoic Acid; Female; Humans; Male; Middle Aged; Odds Ratio; Phosphorylcholine; Prospective Studies; rho-Associated Kinases; Signal Transduction; Sphingosine; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial

2014

Other Studies

2 other study(ies) available for phosphorylcholine and cardiovascular agents

ArticleYear
Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries.
    The Journal of invasive cardiology, 2002, Volume: 14, Issue:5

    Topics: Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Humans; In Vitro Techniques; Iodine Radioisotopes; Oligopeptides; Peptides, Cyclic; Phosphorylcholine; Saphenous Vein; Somatostatin; Stents; Swine; Tunica Intima

2002
Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Dec-01, Volume: 70, Issue:7

    Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Germany; Humans; Male; Middle Aged; Phosphorylcholine; Prospective Studies; Prosthesis Design; Severity of Illness Index; Stainless Steel; Tantalum; Time Factors; Treatment Outcome

2007